Vietnam play to list in Hong Kong

International is an interesting mix of Vietnam-cum-China play, and potential biotech play.

With what is estimated to be a $40 million IPO, valuing the company in small-cap territory of $160 million, Vedan International is not exactly a megadeal.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media